Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Ventricle Health | 2023 | Seed | $8.0M | Greensboro |
| Mariana Oncology | 2023 | Series B | $175.0M | Watertown |
| ExcepGen | 2023 | Seed | $4.0M | San Francisco |
| Capacity Bio | 2023 | Series A | $35.0M | Palo Alto |
| Cooks Venture | 2023 | Venture - Series Unknown | $47.7M | Decatur |
| Expansion Therapeutics | 2023 | Venture - Series Unknown | $6.9M | San Diego |
| Verdiva Bio | 2025 | Series A | Undisclosed | London |
| Diagonal Therapeutics | 2026 | Series B | $125.0M | Watertown |
| Phathom Pharmaceuticals | 2026 | Post-IPO Equity | Undisclosed | Florham Park |
| Nautilus Biotechnology | 2026 | Grant | Undisclosed | San Carlos |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 126 | Ventricle Health | Seed | $8.0M | Greensboro, United States |
| 127 | Mariana Oncology | Series B | $175.0M | Watertown, United States |
| 128 | ExcepGen | Seed | $4.0M | San Francisco, United States |
| 129 | Capacity Bio | Series A | $35.0M | Palo Alto, United States |
| 130 | Cooks Venture | Venture - Series Unknown | $47.7M | Decatur, United States |
| 131 | Expansion Therapeutics | Venture - Series Unknown | $6.9M | San Diego, United States |
| 132 | Verdiva Bio | Series A | Undisclosed | London, United Kingdom |
| 133 | Diagonal Therapeutics | Series B | $125.0M | Watertown, United States |
| 134 | Phathom Pharmaceuticals | Post-IPO Equity | Undisclosed | Florham Park, United States |
| 135 | Nautilus Biotechnology | Grant | Undisclosed | San Carlos, United States |
Ventricle Health offers evidence-based therapy, remote patient monitoring, patient education, and advocacy services for cardiac care.
Mariana Oncology is a biotechnology research industry.
ExcepGen is solving fundamental underlying problems in drug discovery to create a new generation of therapeutics.
Capacity Bio is a therapeutics company that is focused on mitophagy.
Cooks Venture operates as a regenerative pasture-raised chicken and meat company.
Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.
Verdiva Bio creates cutting-edge treatments that improve results for patients with obesity and cardiometabolic diseases.
Diagonal Therapeutics is a biotechnology startup that develops targeted therapies for cancer and genetic diseases.
Phathom Pharmaceuticals is a biopharmaceutical company.
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.
MARS provides digital financial services with unique card options and rewards programs.
Tourmaline Bio is a biotechnology company that develops medicines to treat inflammatory and immune diseases in patients.
Protara Therapeutics develops transformative therapies for people with cancer and rare diseases with limited treatment options.
Triana Biomedicines is a developer of a molecular glue discovery platform to regulate disease.
Janux Therapeutics develops immunotherapies that generates immune responses to prevent tumors and not affecting a patient’s healthy tissue.
TScan Therapeutics is a biopharmaceutical company focused on the development of immunotherapy treatments for cancer.
Nature’s Toolbox is a biotechnology company that provides a proprietary host-independent biological manufacturing and development platform.
Tasso is a Medical innovation company changing the way diagnostics are delivered
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
BioAge Labs is a clinical-stage biotechnology company that develops therapeutics to treat obesity and metabolic diseases.
Curie Therapeutics is a fully integrated next-generation radiopharmaceutical firm that combines ligand research and radiochemistry experts.
Tenaya Therapeutics a clinical-stage biotechnology company that develops novel therapies to treat heart diseases.
Rivus Pharmaceuticals operates as a biopharmaceutical company dedicated to improving cardio-metabolic health.
Be Biopharma develops engineered B cell medicines for serious genetic diseases.
RA Capital Management has invested in 369 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Therapeutics, Pharmaceutical, Biopharma. The firm invests across 24 different industry categories.
Among tracked funding rounds, Mariana Oncology received $175.0M in a Series B round. RA Capital Management's total known invested capital is $19.0B.
RA Capital Management's average investment size is $91.5M across its portfolio of 369 companies.
Recent RA Capital Management portfolio additions include Ventricle Health, Mariana Oncology, ExcepGen, Capacity Bio, Cooks Venture. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors